Risk Factors for Fibromyalgia and Chronic Widespread Pain: A 12-question Quiz

Slideshow

SAMPLE: Based on current research, what is the prevalence of fibromyalgia in the general population? Plus 11 more questions on fibromyalgia and chronic pain.

A recent review published in the journal Pain examined 60 prospective cohort studies that showed incidence and risk factors for fibromyalgia and chronic widespread pain. Answer the 12 questions below for more insights.
Recent Videos
Primary Care is the Answer to the Migraine Care Gap, Says Headache Specialist
Related Content
IV Ibuprofen Cuts Postop Opioid Use by 23% in Older Adults, Study Finds / image credit ©Monkey Business/stock.adobe.com

IV Ibuprofen Cuts Postop Opioid Use by 23% in Older Adults, Study Finds

Grace Halsey
May 28th 2025
Article

The opioid-sparing IVIB pain management strategy in adults aged 60 and older was effective in the immediate post-surgical period and associated with limited AEs.

Obesity & Pain Management: A Primary Viewpoints Podcast

Obesity & Pain Management: A Primary Viewpoints Podcast

Sydney Jennings
April 27th 2023
Podcast

In our latest episode, an obesity medicine physician explains the importance of a comprehensive plan to manage chronic pain in patients with obesity.

FDA Submission Planned for Nonopioid Cebranopadol Following Positive Phase 3 Results: Tris Pharma Update

FDA Submission Planned for Nonopioid Cebranopadol Following Positive Phase 3 Results: Tris Pharma Update

Grace Halsey
March 13th 2025
Article

Positive findings for postsurgical acute pain relief from the pivotal phase 3 ALLEVIATE-2 trial complete the development program, allowing plans for NDA submission.

Primary Viewpoints Episode 19: Mobile Health Technology for Chronic Pain Management

Primary Viewpoints Episode 19: Mobile Health Technology for Chronic Pain Management

Sydney Jennings
September 29th 2022
Podcast

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Lynn Webster, MD, past president of the American Academy of Pain Medicine.

FDA Approves Expanded Use for Sublocade for Opioid Use Disorder

FDA Approves Expanded Use for Sublocade for Opioid Use Disorder

Patient Care Editorial Staff
February 24th 2025
Article

These label changes to Sublocade from Indivior mark a significant advancement in the management of moderate to severe opioid use disorder.

Investigational Nonopioid Beats Placebo in Phase 3 Trial: Daily Dose / image credit: ©New Africa/AdobeStock

Investigational Nonopioid Beats Placebo in Phase 3 Trial: Daily Dose

Sydney Jennings
February 12th 2025
Article

Your daily dose of the clinical news you may have missed.

© 2025 MJH Life Sciences

All rights reserved.